RFXAP and familial pancreatic carcinoma: EV-miR-212-3p from pancreatic cancer cells decreases MHC II transcription factor RFXAP expression of dendritic cells by targeting RFXAP, leading to reduced MHC II expression and potential immune tolerance [244].